[1] 杨强,彭江,卢世璧,等.组织工程骨软骨复合体的研究进展及展望[J]. 中国矫形外科杂志,2008,16(8): 606-609.[2] Naito Y, Shinoka T, Duncan D, et al. Vascular tissue engineering: towards the next generation vascular grafts. Adv Drug Deliv Rev. 2011;163(4-5):312-323.[3] Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater. 2008;15:100-114.[4] Zhou M, Peng X, Mao C, et al. Primate mandibular reconstruction with prefabricated, vascularized tissue-engineered bone flaps and recombinant human bone morphogenetic protein-2 implanted in situ. Biomaterials. 2010; 31(18):4935-4943. [5] Johnson EO, Troupis T, Soucacos PN. Tissue-engineered vascularized bone grafts: basic science and clinical relevance to trauma and reconstructive microsurgery. Microsurgery. 2011; 31(3):176-182.[6] Kneser U, Schaefer DJ, Polykandriotis E, et al. Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med. 2006;10(1):7-19.[7] Zhou J, Lin H, Fang T, et al. The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone. Biomaterials. 2010;31(6):1171-1179. [8] Brey EM, Uriel S, Greisler HP, et al. Therapeutic neovascularization: contributions from bioengineering. Tissue Eng. 2005;11(3-4):567-584.[9] Frhlich M, Grayson WL, Wan LQ, et al. Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther. 2008;3(4):254-264.[10] Hibino N, Villalona G, Pietris N, et al. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. FASEB J. 2011;25(8):2731- 2739. [11] Colton CK. Implantable biohybrid artificial organs. Cell Transplant. 1995;4(4):415-436. [12] Brandi ML, Collin-Osdoby P. Vascular biology and the skeleton. J Bone Miner Res. 2006;21(2):183-192.[13] Correia C, Grayson WL, Park M, et al. In vitro model of vascularized bone: synergizing vascular development and osteogenesis. PLoS One. 2011;6(12):e28352. [14] Koike N, Fukumura D, Gralla O, et al. Tissue engineering: creation of long-lasting blood vessels. Nature. 2004;428 (6979):138-139.[15] Tsigkou O, Pomerantseva I, Spencer JA, et al. Engineered vascularized bone grafts. Proc Natl Acad Sci U S A. 2010; 107(8):3311-3316. [16] Buschmann J, Welti M, Hemmi S, et al. Three-dimensional co-cultures of osteoblasts and endothelial cells in DegraPol foam: histological and high-field magnetic resonance imaging analyses of pre-engineered capillary networks in bone grafts. Tissue Eng Part A. 2011;17(3-4):291-299.[17] Arkudas A, Beier JP, Pryymachuk G, et al. Automatic quantitative micro-computed tomography evaluation of angiogenesis in an axially vascularized tissue-engineered bone construct. Tissue Eng Part C Methods. 2010;16(6): 1503-1514.[18] Beier JP, Horch RE, Hess A, et al. Axial vascularization of a large volume calcium phosphate ceramic bone substitute in the sheep AV loop model. J Tissue Eng Regen Med. 2010; 4(3):216-223.[19] Marquass B,Somerson JS,Hepp P,et al.A novel MSC-seededtriphasic construct for the repair ofosteochondral defects.J Orthop Res. 2010;28(12):1586-1599.[20] 荆立忠,郭秦炜,胡跃林.不同年龄阶段家兔髂软骨组织学特点[J].中国运动医学杂志,2012,31(2):124-128.[21] 王海彬,何伟,袁浩.骨细胞和I型胶原[J].中国中医骨伤科杂志, 2003,11(3):56-59.[22] Deng L Lv J,Pang J,et al.Construction oftissue-engineered OS-teochondral composites and repair of large joint defects in rabbit. J Tissue Eng Regen Med. 2012. [Epub ahead of print].[23] Castro NJ,Hacking SA,Zhang LG.Recent progress in interfacialtissue engineering approaches for osteochondral defects. Ann Biomed Eng. 2012;40(8):1628-1640.[24] Khanarian NL,Haney NM, Burga RA,et al.Afunctional agarose-hydroxyapatite scafold for osteochondral interface regeneration.Biomaterials. 2012;33(21):5247-5258.[25] Rodrigues MT,Lee SJ,Gomes ME,et al.Bilayered constructsaimed at osteochondral strategies: the influence of mediumsupplements in the osteogenic and chondrogenic diferentiation ofamniotic fluid-derived stem cells.Acta Biomater. 2012;8(7):2795-2806.[26] Harichandan A, Buhring HJ. Prospective isolation of human MSC. Best Pract Res Clin Haematol. 2011;24(1):25-36.[27] Nery AA, Nascimento IC, Glaser T, et al. Humanmesenchymal stem cells:from immunophenotyping by flowcytometry to clinical applications. Cytometry A. 2013; 831(1):48-61.[28] Park JS, Shim MS, Shim SH, et al. Chondrogenic potential ofstem cells derived from amniotic fluid,adipose tissue,or bonemarrow encapsulated in fibrin gels containing TGF-β3. Biomaterials. 2011;32(32):8139-8149.[29] Perrier E, Ronziere MC, Bareille R, et al. Analysis of collagenexpression during chondrogenic induction of human bonemarrow mesenchymal stem cells. Biotechnol Lett. 2011; 33(10):2091-2101.[30] Mahnoudifar N, Doran PM. Chondrogenesis and cartilage tissue engineering the longer road to technology development. Trends Biotechnol. 2012;30(3):166-176.[31] 张清林,吕惠成,吴一民.转化生长因子β1联合骨形态发生蛋白2诱导骨髓间充质干细胞体外向软骨细胞的分化[J].中国组织工程研究与临床康复,2010,14(24):4371-4375.[32] Park JS, Yang HN, Woo DG, et al. The promotion ofchondrogenesis, osteogenesis, and adipogenesis of human mesenchymal stem cells by multiple growth factors incorporated into nanosphere-coated microspheres. Biomaterials. 2011;32(1):28-38.[33] Bosetti M, Boccafoschi F, Leigheb M, et al. Chondrogenic induction of human mesenchymal stem cells using combined growth factors for cartilage tissue engineering. J Tissue Eng Regen Med. 2012;6(3):205-213.[34] Hildner F, Concaro S, Peterbauer A, et al. Human adipose-derived stem cells contribute to chondrogenesis in coculture with human articular chondrocytes. Tissue Eng Pt A. 2009;15(12):3961-3969.[35] Mo XT, Guo SC, Xie HQ, et al. Variations in the ratios of co-cultured mesenchymal stem cells and chondrocytes regulate the expression of cartilaginous and osseous phenotype in alginate constructs. Bone. 2009;45(1):42-51.[36] Tew SR, Murdoch AD, Rauchenberg RP, et al. Cellular methods in cartilage research:Primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells. Methods. 2008;45(1):2-9.[37] Fischer J, Dickhut A, Rickert M, et al. Human articul archondrocytes secrete parathyroid hormone- related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondro- genesis. Arthritis Rheum. 2010; 62(9):2696-2706.[38] Chen WH, Lai MT, Wu AT, et al. In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes. Arthritis Rheum. 2009;60(2):450-459.[39] Niyibizi C, Wang S, Mi Z, et al. The fate of mesenchymal stem cells transplanted into immunecompetent neonatal mice:implications for skeletal gene therapy via stem cells. Mol Ther. 2004;9(9):955-963.[40] Quintana L, zur Nieden NI, Semino CE. Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering. Tissue Eng Part B Rev. 2009;15(1):29-41. |